Authors: McKay, RG Boden, WE

Citation: Rg. Mckay et We. Boden, Small peptide GP IIb/IIIa receptor inhibitors as upstream therapy in non-ST-segment elevation acute coronary syndromes: results of the PURSUIT, PRISM, PRISM-PLUS, TACTICS, and PARAGON trials, CURR OPIN C, 16(6), 2001, pp. 364-369

Authors: Boden, WE McKay, RG

Citation: We. Boden et Rg. Mckay, Optimal treatment of acute coronary syndromes - An evolving strategy., N ENG J MED, 344(25), 2001, pp. 1939-1942

Authors: Giri, S Mitchel, JF Hirst, JA McKay, RG Azar, RR Mennett, R Waters, DD Kiernan, FJ

Citation: S. Giri et al., Synergy between intracoronary stenting and abciximab improving angiographic and clinical outcomes of primary angioplasty in acute myocardial infarction, AM J CARD, 86(3), 2000, pp. 269-274

Authors: Azar, RR Waters, DD McKay, RG Giri, S Hirst, JA Mitchell, JF Fram, DB Kiernan, FJ

Citation: Rr. Azar et al., Short and medium-term outcome differences in women and men after primary percutaneous transluminal mechanical revascularization for acute myocardial infarction, AM J CARD, 85(6), 2000, pp. 675-679

Authors: Giri, S Thompson, PD Kiernan, FJ Clive, J Fram, DB Mitchel, JF Hirst, JA McKay, RG Waters, DD

Citation: S. Giri et al., Clinical and angiographic characteristics of exertion-related acute myocardial infarction, J AM MED A, 282(18), 1999, pp. 1731-1736

Authors: Azar, RR McKay, RG Thompson, PD Hirst, JA Mitchell, JF Fram, DB Waters, DD Kiernan, FJ

Citation: Rr. Azar et al., Abciximab in primary coronary angioplasty for acute myocardial infarction improves short- and medium-term outcomes, J AM COL C, 32(7), 1998, pp. 1996-2002